AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35102364 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal hop extract (500 mg, delayed-release capsules)
Number of subjects: 19
Study 35102364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 36203149 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E malaria vaccine (primary series and two seasonal boosters) and seasonal malaria chemoprevention (four monthly cycles per year)
Number of subjects: 5920
Study 36203149 — intervention group
Group type: COMPARATOR
Intervention: Seasonal malaria chemoprevention (SMC)
Number of subjects: 5920
Study 36203149 — intervention group
Group type: COMPARATOR
Intervention: RTS,S/AS01E malaria vaccine alone
Number of subjects: 5920
Study 36203149 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of SMC and RTS,S/AS01E
Number of subjects: 5920
Study 33759752 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient pulmonary rehabilitation (PR) for 3 weeks
Number of subjects: 412
Study 33759752 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (CG)
Number of subjects: 412
Study 36240478 — intervention group
Group type: EXPERIMENTAL
Intervention: Rogaratinib (800 mg orally twice daily, 3-week cycles)
Number of subjects: 175
Study 36240478 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (docetaxel 75 mg/m2, paclitaxel 175 mg/m2, or vinflunine 320 mg/m2 intravenously once every 3 weeks)
Number of subjects: 175
Study 36240478 — intervention group
Group type: EXPERIMENTAL
Intervention: Rogaratinib (in exploratory analysis)
Number of subjects: 175
Study 36240478 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (in exploratory analysis)
Number of subjects: 175
Study 34081408 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tetanus vaccine (TeNT-Hc 10/20/30 µg)
Number of subjects: 150
Study 34081408 — intervention group
Group type: COMPARATOR
Intervention: Tetanus toxoid (TT) vaccine
Number of subjects: 150
Study 34081408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 36254383 — intervention group
Group type: EXPERIMENTAL
Intervention: Assembly-type guide device
Number of subjects: 54
Study 36254383 — intervention group
Group type: EXPERIMENTAL
Intervention: C-shape device
Number of subjects: 54
Study 36254383 — intervention group
Group type: COMPARATOR
Intervention: Free-hand technique
Number of subjects: 54
Study 33268022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus Olanzapine
Number of subjects: 269
Study 33268022 — intervention group
Group type: COMPARATOR
Intervention: Sertraline plus Placebo
Number of subjects: 269
Study 35488323 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CBT + usual care
Number of subjects: 90
Study 35488323 — intervention group
Group type: EXPERIMENTAL
Intervention: MFG + usual care
Number of subjects: 90
Study 35488323 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study 34919616 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Restoration (IR)
Number of subjects: 40
Study 34919616 — intervention group
Group type: COMPARATOR
Intervention: Delayed Restoration (DR)
Number of subjects: 40
Study 33377537 — intervention group
Group type: EXPERIMENTAL
Intervention: Odds and hazard ratios
Number of subjects: 0
Study 33377537 — intervention group
Group type: EXPERIMENTAL
Intervention: Redefined odds and hazards ratio causal estimands
Number of subjects: 0
Study 34737784 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive rehabilitation care
Number of subjects: 120
Study 32623626 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple P‐Positive Parenting Program
Number of subjects: 240
Study 32623626 — intervention group
Group type: COMPARATOR
Intervention: Control group (general population mothers)
Number of subjects: 240
Study 35538523 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention through social network within 16 training sessions related to physical activity and nutrition in 8 weeks
Number of subjects: 90
Study 34726760 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital P.A.R.T.Y. program
Number of subjects: 952
Study 34726760 — intervention group
Group type: EXPERIMENTAL
Intervention: On-base P.A.R.T.Y. program
Number of subjects: 952
Study 34726760 — intervention group
Group type: COMPARATOR
Intervention: Control group (annual alcohol and other drugs awareness training only)
Number of subjects: 952
Study 34424869 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (2 mg/kg, twice daily preoperatively and for 5 days postoperatively)
Number of subjects: 64
Study 34424869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34424869 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 64
Study 32094154 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention programme (three monthly community clinics treating wet cough with prolonged antibiotics)
Number of subjects: 400
Study 32094154 — intervention group
Group type: COMPARATOR
Intervention: Usual pathway of parent‐initiated healthcare access (control)
Number of subjects: 400
Study 36457648 — intervention group
Group type: EXPERIMENTAL
Intervention: SLNB (Sentinel Lymph Node Biopsy)
Number of subjects: 5154
Study 36457648 — intervention group
Group type: COMPARATOR
Intervention: No SLNB
Number of subjects: 5154
Study 36457648 — intervention group
Group type: EXPERIMENTAL
Intervention: ALND (Axillary Lymph Node Dissection)
Number of subjects: 5154
Study 33676526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-congruent fixed (UC) implant
Number of subjects: 24
Study 33676526 — intervention group
Group type: EXPERIMENTAL
Intervention: UCR Columbus Total Knee System
Number of subjects: 24
Study 33676526 — intervention group
Group type: EXPERIMENTAL
Intervention: Low congruent fixed (CR DD) implant
Number of subjects: 24
Study 33676526 — intervention group
Group type: COMPARATOR
Intervention: Control group (9 participants)
Number of subjects: 24
Study 32629997 — intervention group
Group type: COMPARATOR
Intervention: Antenatal intervention for Class III women
Number of subjects: 1555
Study 32629997 — intervention group
Group type: COMPARATOR
Intervention: Antenatal intervention for Class I and II women
Number of subjects: 1555
Study 36004820 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Training (BT)
Number of subjects: 28
Study 36004820 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 28
Study 34300310 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 µg/kg/h)
Number of subjects: 56
Study 34300310 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study 32621374 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT) analyzers implemented in the ED
Number of subjects: 23231
Study 32621374 — intervention group
Group type: COMPARATOR
Intervention: Central laboratory
Number of subjects: 23231
Study 35162447 — intervention group
Group type: EXPERIMENTAL
Intervention: FLOSS intervention
Number of subjects: 20
Study 35162447 — intervention group
Group type: COMPARATOR
Intervention: ELA control
Number of subjects: 20
Study 33307633 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversalis fascia plane (TFP) block with 0.4 mL/kg bupivacaine 0.25%
Number of subjects: 40
Study 33307633 — intervention group
Group type: COMPARATOR
Intervention: Control group with 0.9% saline
Number of subjects: 40
Study 35189286 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial-Stabilized (MS) device
Number of subjects: 200
Study 35189286 — intervention group
Group type: COMPARATOR
Intervention: Posterior-Stabilized (PS) device
Number of subjects: 200
Study 34430755 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander-based violence intervention 'Green Dot'
Number of subjects: 25
Study 35552492 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition, hygiene, and stimulation education intervention among mothers
Number of subjects: 344
Study 35552492 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiota
Number of subjects: 344
Study 35552492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention and microbiota
Number of subjects: 344
Study 32818600 — intervention group
Group type: EXPERIMENTAL
Intervention: Musically trained subjects
Number of subjects: 0
Study 32818600 — intervention group
Group type: COMPARATOR
Intervention: Musically untrained subjects
Number of subjects: 0
Study 32818600 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulus contrast focusing on visual motion percept of moving fingers on piano keys in trained subjects
Number of subjects: 0
Study 32818600 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of training in trained subjects
Number of subjects: 0
Study 32818600 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative analysis of individual brain volumes in trained subjects
Number of subjects: 0
Study 35362101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 52
Study 35362101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 32920228 — intervention group
Group type: EXPERIMENTAL
Intervention: 70‐min PNE lecture
Number of subjects: 37
Study 32920228 — intervention group
Group type: COMPARATOR
Intervention: 70‐min control education
Number of subjects: 37
Study 35157638 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0
Study 35157638 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise
Number of subjects: 0
Study 35157638 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study 34288127 — intervention group
Group type: EXPERIMENTAL
Intervention: HEPA air cleaners
Number of subjects: 71
Study 34288127 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study 32325778 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 and Vitamin D supplement (510 mg DHA, 344 mg EPA, 1000 IU vitamin D)
Number of subjects: 0
Study 32325778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35226749 — intervention group
Group type: EXPERIMENTAL
Intervention: Preheated resin composite (RC)
Number of subjects: 35
Study 35226749 — intervention group
Group type: COMPARATOR
Intervention: Nonheated resin composite (RC)
Number of subjects: 35
Study 33211204 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm temperature group
Number of subjects: 105
Study 33211204 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium temperature group
Number of subjects: 105
Study 33211204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool temperature group
Number of subjects: 105
Study 32112772 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheimpflug imaging pachymetry and posterior elevation maps
Number of subjects: 0
Study 35419807 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP8302 (100 mg, oral, once daily for 4 weeks)
Number of subjects: 135
Study 35419807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 35419807 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP8302
Number of subjects: 135
Study 33482782 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic musculoskeletal pain (CMP) patients
Number of subjects: 969
Study 33482782 — intervention group
Group type: COMPARATOR
Intervention: Patients without chronic musculoskeletal pain (no CMP)
Number of subjects: 969
Study 34739075 — intervention group
Group type: EXPERIMENTAL
Intervention: venetoclax-azacitidine
Number of subjects: 37
Study 34739075 — intervention group
Group type: COMPARATOR
Intervention: placebo-azacitidine
Number of subjects: 37
Study 33935055 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Pilates exercises (CPE)
Number of subjects: 55
Study 33935055 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study 35139809 — intervention group
Group type: EXPERIMENTAL
Intervention: Group transdiagnostic cognitive-behavioural therapy (tCBT)
Number of subjects: 0
Study 35139809 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual transdiagnostic cognitive-behavioural therapy (tCBT)
Number of subjects: 0
Study 35139809 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 36314204 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practice (MAP)
Number of subjects: 55
Study 36314204 — intervention group
Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 55
Study 32841683 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine liver decomposition product (PLDP) - 4 capsules for 4 weeks
Number of subjects: 58
Study 32841683 — intervention group
Group type: COMPARATOR
Intervention: Placebo - 4 capsules for 4 weeks
Number of subjects: 58
Study 36416089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii Fit
Number of subjects: 23
Study 36416089 — intervention group
Group type: COMPARATOR
Intervention: Home-based fun video exercises
Number of subjects: 23
Study 33910419 — intervention group
Group type: COMPARATOR
Intervention: TLR4 Asp299Gly genotype
Number of subjects: 84
Study 33910419 — intervention group
Group type: COMPARATOR
Intervention: TLR4 Thr399Ile genotype
Number of subjects: 84
Study 33910419 — intervention group
Group type: COMPARATOR
Intervention: TLR9 T1237C genotype
Number of subjects: 84
Study 32281095 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine solution administered via new catheter
Number of subjects: 252
Study 32281095 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine gel
Number of subjects: 252
Study 35124338 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 46
Study 35124338 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation
Number of subjects: 46
Study 33958243 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol in combination with dexmedetomidine
Number of subjects: 44
Study 33958243 — intervention group
Group type: COMPARATOR
Intervention: Butorphanol combined with saline (control group)
Number of subjects: 44
Study 32443302 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-ketamine (1 mg/kg ketamine, 1 μg/kg dexmedetomidine loading dose over 10 minutes, followed by infusion at 0.6 μg/kg/h for 20 minutes)
Number of subjects: 46
Study 32443302 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine-fentanyl (1 μg/kg fentanyl, 1 μg/kg dexmedetomidine loading dose over 10 minutes, followed by infusion at 0.6 μg/kg/h for 20 minutes)
Number of subjects: 46
Study 35378136 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐POEM (Gastric peroral endoscopic myotomy)
Number of subjects: 374
Study 34236392 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich vegetable group (n=25)
Number of subjects: 77
Study 34236392 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice group (n=26)
Number of subjects: 77
Study 34236392 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=26)
Number of subjects: 77
Study 32468448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra Rapid Lispro (URLi)
Number of subjects: 38
Study 32468448 — intervention group
Group type: COMPARATOR
Intervention: Humalog® (Lispro)
Number of subjects: 38
Study 35975659 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity advice and social support as an add-on to usual care
Number of subjects: 0
Study 35975659 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 34018344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesdopetam (IRL790) single dose (up to 120 mg)
Number of subjects: 0
Study 34018344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesdopetam (IRL790) multiple doses (up to 80 mg)
Number of subjects: 0
Study 34018344 — intervention group
Group type: COMPARATOR
Intervention: Mesdopetam (IRL790)
Number of subjects: 0
Study 32951002 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 45
Study 32192396 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral agar (600 mg/kg/day dissolved in 10 ml distilled water, twice daily until TSB decreased to 7 mg/dl)
Number of subjects: 160
Study 32192396 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral agar plus phototherapy
Number of subjects: 160
Study 32192396 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy alone
Number of subjects: 160
Study 34580498 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilisation with movement
Number of subjects: 34
Study 34580498 — intervention group
Group type: COMPARATOR
Intervention: Mulligan knee taping
Number of subjects: 34
Study 34580498 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 34
Study 32366963 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI (kg/m2)
Number of subjects: 675697
Study 32366963 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization methods using 76 independent BMI-associated SNPs
Number of subjects: 675697
Study 32366963 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian colocalization methods
Number of subjects: 675697
Study 35723701 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 78
Study 35723701 — intervention group
Group type: COMPARATOR
Intervention: Primary arthrodesis (PA)
Number of subjects: 78
Study 32694374 — intervention group
Group type: EXPERIMENTAL
Intervention: EtOH ingestion (0.1 g·kg lean body mass·h; 30.2 ± 1.1 g 40% ABV Vodka)
Number of subjects: 8
Study 32694374 — intervention group
Group type: COMPARATOR
Intervention: Control (no EtOH ingestion)
Number of subjects: 8
Study 32694374 — intervention group
Group type: EXPERIMENTAL
Intervention: EtOH ingestion
Number of subjects: 8
Study 32694374 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 35395620 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory biofeedback (AudFB) during gait training
Number of subjects: 18
Study 35395620 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instructions during sessions)
Number of subjects: 18
Study 35395620 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (AudFB and Control)
Number of subjects: 18
Study 34225722 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyad training
Number of subjects: 41
Study 34225722 — intervention group
Group type: COMPARATOR
Intervention: Individual training
Number of subjects: 41
Study 35821785 — intervention group
Group type: EXPERIMENTAL
Intervention: Licaminlimab (60 mg/mL ophthalmic solution)
Number of subjects: 134
Study 35821785 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 134
Study 34345965 — intervention group
Group type: EXPERIMENTAL
Intervention: Viable probiotic tablets (Lactobacillus salivarius subsp. salicinius AP‐32, Bifidobacterium animalis subsp. lactis CP‐9, Lactobacillus paracasei ET‐66)
Number of subjects: 45
Study 34345965 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-killed probiotic tablets (Lactobacillus salivarius subsp. salicinius AP‐32, Lactobacillus paracasei ET‐66)
Number of subjects: 45
Study 34345965 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 45
Study 34586472 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 136
Study 34586472 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine
Number of subjects: 136
Study 32441868 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia symptoms (self-reported)
Number of subjects: 319
Study 32441868 — intervention group
Group type: EXPERIMENTAL
Intervention: High non-restorative index (subjective)
Number of subjects: 319
Study 32441868 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher amounts of rapid eye movement (REM) sleep
Number of subjects: 319
Study 32441868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbances (self-reported)
Number of subjects: 319
Study 32441868 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated REM sleep
Number of subjects: 319
Study 33002731 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS-γ tACS
Number of subjects: 0
Study 33002731 — intervention group
Group type: EXPERIMENTAL
Intervention: cTBS-γ tACS
Number of subjects: 0
Study 33002731 — intervention group
Group type: COMPARATOR
Intervention: iTBS-sham tACS
Number of subjects: 0
Study 33002731 — intervention group
Group type: COMPARATOR
Intervention: cTBS-sham tACS
Number of subjects: 0
Study 35484369 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 275
Study 33443913 — intervention group
Group type: EXPERIMENTAL
Intervention: Limberg flap repair
Number of subjects: 234
Study 33443913 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 234
Study 34201821 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortification with multiple micronutrient powder
Number of subjects: 162
Study 34201821 — intervention group
Group type: COMPARATOR
Intervention: Standard drug supplementation of ferrous sulfate associated with folic acid
Number of subjects: 162
Study 32286894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cacao by-products
Number of subjects: 0
Study 32286894 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study 33926835 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal radial artery (dRA) access
Number of subjects: 0
Study 33926835 — intervention group
Group type: COMPARATOR
Intervention: Proximal radial artery (pRA) access
Number of subjects: 0
Study 33572909 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (n = 28) - high-intensity interval training with TRX, 90-95% max HR, 12 weeks, 2 times/week, 45 min/session
Number of subjects: 82
Study 33572909 — intervention group
Group type: EXPERIMENTAL
Intervention: MIIT (n = 27) - moderate-intensity interval training with TRX, 70% max HR, 12 weeks, 2 times/week, 45 min/session
Number of subjects: 82
Study 33572909 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) (n = 27) - continued daily lifestyle
Number of subjects: 82
Study 35742753 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Exercise (IE)
Number of subjects: 7
Study 35742753 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE)
Number of subjects: 7
Study 35742753 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 7
Study 36281668 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication therapy management
Number of subjects: 90
Study 36281668 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 90
Study 34897869 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep breathing exercise with Triflo
Number of subjects: 44